US 2026/0297148 A1 · Keratin YK93-5, Preparation Method, and Pharmaceutical Composition and Use Thereof

Abstract

The present invention relates to the field of biological pharmacy, provides keratin YK93-5, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell containing the expression vector or a genome integrated with the nucleic acid molecule, a preparation method for the keratin YK93-5, and a pharmaceutical composition of the keratin YK93-5, and further provides a use of the products such as the keratin YK93-5 in the preparation of drugs for treating lung cancer, lymphoma, breast cancer, melanoma, uterine fibroids, prostatic hyperplasia, etc.

Claims16

Dependent claims

A keratin YK93-5, wherein the amino acid sequence of the keratin YK93-5 is:

(1) the amino acid sequence set forth in SEQ ID NO.1 in the sequence listing;
or
(2) an amino acid sequence formed by substitution, deletion or addition of 1-35 amino acids in the amino acid sequence set forth in SEQ ID NO.1 in the sequence listing that basically maintains the same biological function.

Dependencies are inferred from the claim text.

Keratin YK93-5, Preparation Method, and Pharmaceutical Composition and Use Thereof

Life of this patent

Keratin YK93-5, Preparation Method, and Pharmaceutical Composition and Use Thereof

Life of this patent

Abstract

Claims16